171
Arrowhead Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−136
FY23:
−154
FY24:
−463
FY25:
180
Change from FY21 to FY25
millions USD
FY21:
−142
FY22:
−5.42
FY23:
−96.2
FY24:
−420
FY25:
−129
Change from FY21 to FY25
millions USD
FY21:
11.3
FY22:
65.2
FY23:
253
FY24:
871
FY25:
74.0
millions USD
FY21:
40.9
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
148
FY22:
−189
FY23:
−331
FY24:
−604
FY25:
157
All amounts in millions USD